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First molecular genetic test 
Continued ji·om Jlt?,�e I 
The test requires only a few drops 
of blood from which the genetic code 
(DNA) is extracted and tested for the 
presence of the mutation by a poly­
merase chain reaction, a modern labora­
tory technique. Dogs can be tested at any 
age, even right after birth, allowing early 
determination of whether an animal has 
affected, carrier. or normal status. 
Because of the intermittent and 
variable clinical signs and the suspected 
high prevalence of PFK deficiency in the 
English springer spaniel breed. Dr. Giger 
recommends the resting of all English 
Springer spaniels with suggestive clinical 
signs and all springers used for field tri­
aling or breeding, or prior to purchase of 
a springer puppy. Affected dogs should 
not b e  bred, and appropriate precautions 
taken to ensure their health and welfare. 
It is not recommended that carrier dogs 
be used for breeding; however, if they 
are bred, they should only be bred to 
dogs tested as normal, and all of the 
resulting puppies should be tested. 
Carrier puppies should be neutered and 
National Award for Penn Researcher 
A Burroughs WeUcome Fund New 
Investigator Award in Molecular 
Parasitology for I 993 was awarded to 
Or. Phillip Scott, assistant professor of 
parasitology at the University of Penn­
sylvania School of Veterinary Medicine. 
The $60,000 award, provided over two 
years, will enable Dr. Scott to continue 
his work on the development of a vac­
cine against leishmaniasis. This disease, 
caused by a parasite. affects man and 
animals in Central and South America, 
Africa, southern Europe and the Middle 
East. If not treated it can cause severe 
disfigurement and even death. 
Dr. Scott's research focuses on 
studying the immune responses associ­
ated with the parasite, Leishmania. The 
foundation for the studies are Dr. Scon's 
observations that the stimulation of dif­
ferent types of immune cells determine 
Whether the parasite is eliminated, or 
whether the infection is eventually fatal. 
These findings are usefuJ not only in 
understanding leishmaniasis but also in 
understanding immunity in several other 
diseases, since these different cell types 
are important in controlling many infec­
tious diseases, including parasitic, bacte­
rial and viral infections, as well as aller­
gies and autoimmune disease. Thus 
advances made in the leishmania! model 
may be widely applicable. 
rn the past, vaccine development 
has been. for the most part. done empiri­
cally. Dr. Scott's research will involve 
2 
identification of molecules that act to 
stimulate the development of particular 
types of immune cells. With this knowl­
edge. it is thought that researchers may 
be able to design vaccines of the future 
more rationaJiy. 
The Molecular Parasitology Award 
Program is offered annually by The 
Burroughs Wellcome Fund to recognize 
the pioneering contributions of Sir Henry 
Wellcome to the study of tropical medi­
cine. and to support the applicaLion of 
modem developments in biology and 
normal puppies used to continue the 
breeding program. By testing and breed­
ing appropriately, PFK deficiency can be 
rapidly eliminated from this breed, and 
the further spread of this disease and 
future suffering of affected animals can 
be prevented. 
For further information on testing 
dogs, please contact Drs. Urs Giger/Beth 
Callan, School of Veterinary Medicine, 
University of Pennsylvania. 3850 Spruce 
Street, Philadelphia, PA 19l04-6010 
(FAX 215-573-'2162). 
chemistry to the understanding, control 
and prevention of parasitic diseases. 
Dr. Scott is the first researcher 
associated with a veterinary school to 
receive the award. Two other 1993 New 
Investigator awards were presented to 
scientists at other institutions. 
The Burroughs Wellcome Fund is a 
private, non-profit foundation estab­
lished in 1955 ''To provide financial aid 
for the advancement of medical knowl­
edge by research. and for other scientific. 
scholarly and educational purposes:· 
